1-6 of 6
Else Heidemann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, MD, Ernst Holler, MD, Monika Engelhardt, MD, Bernd Metzner, MD, Dietrich Peest, MD, Walter Aulitzky, MD, Donald W. Bunjes, MD, Christian Straka, MD, Thomas Fischer, MD, Hannes Wandt, MD, Orhan Sezer, MD, Markus Hentrich, MD, Helmut Ostermann, MD, Christian Peschel, MD, Georg Hess, MD, Bernd Hertenstein, MD, Mathias Freund, MD, Martin H Kropff, MD, Hans-Heinrich Wolf, MD, Wolfram E Jung, MD, Norbert Frickhofen, MD, Ralf C. Bargou, Georg Maschmeyer, MD, Else Heidemann, MD, Christian Langer, MD, Lothar Kanz, MD, Christoph Meisner, PhD, Hermann Einsele, MD
Journal: Blood
Blood (2014) 124 (21): 43.
https://doi.org/10.1182/blood.V124.21.43.43
Published: 2014
Journal Articles

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Christian Straka, MD, Kerstin Schaefer-Eckart, MD, Florian Bassermann, MD, Hansen Timon, MD, Bernd Hertenstein, MD, Christian Langer, MD, Hans Salwender, MD, Stefan Knop, MD, Monika Engelhardt, MD, Martin Kropff, MD, Wolf Roesler, MD, Thomas Decker, MD, Holger Hebart, MD, Norbert Frickhofen, MD, Albrecht Reichle, Christian Gerecke, MD, Bernd Metzner, Else Heidemann, MD, Tim H Brummendorf, MD, Juliane Ababei, MD, Wolfram E Jung, MD, Martin Gramatzki, MD, Marcus Hentrich, MD, Peter Bojko, MD, Ivana von Metzler, MD, Martin Kaufmann, MD, Ralph Naumann, MD, Thomas Kubin, MD, Burkhard Schmidt, MD, Jochem Walther, MD, Tobias Dechow, MD, Hannes Wandt, MD, Brigitte Schnabel, Axel Hinke, PhD, Hermann Einsele
Journal: Blood
Blood (2014) 124 (21): 3969.
https://doi.org/10.1182/blood.V124.21.3969.3969
Published: 2014
Journal Articles

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Christian Straka, Kerstin Schäfer-Eckart, Florian Bassermann, Bernd Hertenstein, Monika Engelhardt, Hans Salwender, MD, Wolf Rösler, Christian Langer, Georgia Schilling, Stefan Knop, Tim H Brümmendorf, Bernd Metzner, Holger Hebart, Albrecht Reichle, Norbert Frickhofen, MD, Else Heidemann, Juliana Ababei, Christian Gerecke, Wolfram Jung, Martin Gramatzki, Thomas Decker, Martin Kropff, MD, Ralph Naumann, Marcus Hentrich, Jochem Walther, Peter Bojko, Tobias Dechow, Hannes Wandt, Axel Hinke, Hermann Einsele
Journal: Blood
Blood (2012) 120 (21): 2012.
https://doi.org/10.1182/blood.V120.21.2012.2012
Published: 2012
Journal Articles

Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).

Hermann Einsele, Peter Liebisch, Christian Langer, Martin Kropff, Hannes Wandt, Wolfram Jung, Nikolaus Kröger, Monika Engelhardt, Helmut Ostermann, Lars-Olof Mügge, Hans-Heinrich Wolf, Christina Hart, Bernd Metzner, Martin Kaufmann, Martin Gramatzki, Bernd Hertenstein, Thomas Fischer, Katja Weisel, Gottfried Dölken, Wolfram Brugger, Hella Gollasch, Georg Maschmeyer, Michael Pfreundschuh, Norbert Schmitz, Orhan Sezer, Else Heidemann, Elke Jäger, Christoph Kahl, Alexander Kiani, Tobias Dechow, Wolf Rösler, Jan Philipp Simon, Heinz Dürk, Karl Heinz Pflüger, Martin Bentz, Georg Hess, Hans-Guenther Mergenthaler, Christian Straka, Dirk Hempel, Hans-Jürgen Salwender, Günter Fingerle-Rowson, Stefan Knop
Journal: Blood
Blood (2009) 114 (22): 131.
https://doi.org/10.1182/blood.V114.22.131.131
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, Ernst Holler, PhD, Monika Engelhardt, Ralf C Bargou, MD, Bernd Metzner, Dietrich Peest, Walter E. Aulitzky, MD, Hannes Wandt, MD, Orhan Sezer, MD, PhD, Markus Hentrich, Helmut Ostermann, Christian Peschel, MD, Georg Hess, Bernd Hertenstein, Mathias Freund, MD, Martin H Kropff, Hans-Heinrich Wolf, Wolfram Jung, Norbert Frickhofen, MD, Georg Maschmeyer, Hans-Guenther Mergenthaler, Else Heidemann, Nicolaus Kröger, MD, Christian Straka, Corinna Engel, Lothar Kanz, Christoph Meisner, Hermann Einsele, MD
Journal: Blood
Blood (2009) 114 (22): 51.
https://doi.org/10.1182/blood.V114.22.51.51
Published: 2009
Journal Articles

The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial

Eva Hoster, Michael Unterhalt, PhD, Bernhard Wörmann, Ulrich Dührsen, Bernd Metzner, Hartmut Eimermacher, Andreas Neubauer, Hannes Wandt, Hjalmar Steinhauer, Sonja Martin, Else Heidemann, Ali Aldaoud, Wolfgang Hiddemann, Martin Dreyling
Journal: Blood
Blood (2008) 112 (11): 3049.
https://doi.org/10.1182/blood.V112.11.3049.3049
Published: 2008